Taken together, our work provides important new insights that extend beyond the molecular pathology of CF and CFTR LOF to the global quest for the identification of molecular targets for genetic disorders using transcriptomics and proteomics approaches. The gene discussed is CFTR; the disease is cystic fibrosis.